{"id":6560,"date":"2026-05-21T10:15:07","date_gmt":"2026-05-21T10:15:07","guid":{"rendered":"https:\/\/www.rldatix.com\/engineering\/?p=6560"},"modified":"2026-05-22T13:42:20","modified_gmt":"2026-05-22T13:42:20","slug":"responsible-ai-in-healthcare-software-how-rldatix-decides-what-goes-into-our-products","status":"publish","type":"post","link":"https:\/\/www.rldatix.com\/engineering\/resources\/responsible-ai-in-healthcare-software-how-rldatix-decides-what-goes-into-our-products\/","title":{"rendered":"Responsible AI in Healthcare Software: How\u00a0RLDatix\u00a0Decides What Goes\u00a0Into\u00a0Our Products\u00a0"},"content":{"rendered":"\n

Richard Jarvis, Chief Technology Officer at RLDatix<\/em> <\/strong><\/p>\n\n\n\n

Every healthcare software vendor is being asked the same question right now: what’s your AI strategy, and when are we going to see it? <\/p>\n\n\n\n

The pace of capability change in the underlying technology behind AI has been genuinely remarkable. It’s an exciting moment for the field and one that calls for a clear head about what adoption actually means inside products where human lives are at stake. <\/p>\n\n\n\n

The AI we put inside our products has to behave predictably for the risk managers triaging incident reports, the rostering leads balancing safe staffing levels, the policy teams getting ready for an inspection, and for the patients at the end of every one of those workflows. <\/p>\n\n\n\n

That’s also where the engineering work starts. In healthcare, an AI capability that behaves unpredictably isn’t just a product problem. It’s a safety, regulatory and trust problem. So the discipline we apply upstream in what we test, what we measure and what we’re willing to reverse is what protects the people downstream who are depending on the output to do their jobs well. <\/p>\n\n\n\n

<\/div>\n\n\n\n

How we evaluate AI in healthcare software<\/strong> <\/h2>\n\n\n\n
<\/div>\n\n\n\n

Rather than treating every new model or vendor as a launch decision, we treat it as a hypothesis to be tested. Here are four practices that anchor our approach: <\/p>\n\n\n\n

Hypothesis-led evaluation against representative data<\/strong> <\/h6>\n\n\n\n

Before a capability gets anywhere near a customer, we write down what “good” looks like for the specific task \u2014 not on a public benchmark, but on data that actually reflects the messiness of real clinical and operational records. The hypothesis is explicit (“this model can extract X from Y at quality Z”), and we test it against examples we’ve curated to represent the workflows it will actually touch. <\/p>\n\n\n\n

Pre-agreed success and stop criteria<\/strong> <\/h6>\n\n\n\n

We decide upfront what result would make us proceed and what result would make us stop. This sounds obvious, but it’s the single most important guardrail we have against motivated reasoning when a vendor demo is impressive or a competitor announcement lands the same week. If the numbers don’t clear the bar we set before we started, then we don’t ship. It’s a small discipline that saves a lot of time later. <\/p>\n\n\n\n

Abstraction so model and vendor choices stay reversible<\/strong> <\/h6>\n\n\n\n

The AI landscape changes on a quarterly cadence, sometimes faster. Anyone who’s tried to pick a foundation model in the last year will recognise the feeling. We build our integrations so the model behind a capability, and the vendor providing it, can be swapped without rewriting the product around them. We also make it easy to test new models by supporting safe, low-friction evaluation paths. There’s a small upfront engineering tax, but it keeps us honest: we’re committing to a capability for our customers, not to one supplier’s roadmap. <\/p>\n\n\n\n

Explicit AI governance before customer exposure<\/strong> <\/h6>\n\n\n\n

A capability that has passed evaluation isn’t automatically a capability that’s ready to be used. Before we put it in front of customers, it goes through proper review gates covering safety, data handling, regulatory posture and, importantly, whether the people using it will be able to calibrate their trust in it appropriately. That last point is easy to underestimate. <\/p>\n\n\n\n

<\/div>\n\n\n\n

Three forces pulling the other way<\/strong> <\/h2>\n\n\n\n
<\/div>\n\n\n\n

This discipline only matters because there are real forces pulling against it. Three in particular: <\/p>\n\n\n\n

Rapid vendor price and capability changes<\/strong> <\/h6>\n\n\n\n

Costs and capabilities shift fast enough that a decision made on one quarter’s numbers can look very different the next. We try not to chase every change. Instead, we make sure our architecture lets us revisit a choice when the underlying economics move. <\/p>\n\n\n\n

Competitive pressure to ship<\/strong> <\/h6>\n\n\n\n

When a competitor announces something, the temptation is to compress the evaluation. We’ve found it more useful to just be transparent with ourselves, with our customers and with regulators about what we’ve evaluated, what we haven’t and why. A capability we can stand behind when speaking to a safety lead is worth more than one we shipped on someone else’s timeline. <\/p>\n\n\n\n

Human factors and trust calibration<\/strong> <\/h6>\n\n\n\n

This is probably the hardest of the three. An AI output that’s right 95% of the time is genuinely useful, but only if the person reading it knows how to treat the other 5%. For this reason, we put just as much thought into how a capability is presented \u2014 the framing, the uncertainty signals, where it sits in the workflow \u2014 as we do into the model behind it. The engineering decision and the human decision are inseparable. <\/p>\n\n\n\n

What comes next for responsible AI at RLDatix<\/strong> <\/h6>\n\n\n\n

We’re continuing to refine how we evaluate capabilities against the real-world operational data our customers work with every day, and how we communicate confidence and limitations to the clinicians, risk managers and operations leaders using AI-assisted features. Above all, we prioritize durable, provable performance: AI deployed by us must continue to meet its declared standards year after year \u2014 through procurement cycles, regulatory change and the everyday turbulence of healthcare operations. <\/p>\n\n\n\n

<\/div>\n\n\n\n

FAQs<\/strong> <\/h2>\n\n\n\n
<\/div>\n\n\n\n
\n
\n